Schweiz - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - palbociclibum - capsule rigide - palbociclibum 75 mg, cellulosum microcristallinum, lactosum monohydricum 55.775 mg, carboxymethylamylum natricum a, silica colloidalis anhydrica, magnesii stearas, kapselhülle: gelatina, e 172 (rubrum), e 172 (flavum), e 171, drucktinte: lacca, e 171, ammoniae solutio 28 per centum, propylenglycolum, simeticonum, pro capsula, natrium 1.28 mg. - carcinoma della mammella - synthetika

Schweiz - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - palbociclibum - capsule rigide - palbociclibum 100 mg, cellulosum microcristallinum, lactosum monohydricum 74.367 mg, carboxymethylamylum natricum a, silica colloidalis anhydrica, magnesii stearas, kapselhülle: gelatina, e 172 (rubrum), e 172 (flavum), e 171, drucktinte: lacca, e 171, ammoniae solutio 28 per centum, propylenglycolum, simeticonum, pro capsula, natrium 1.71 mg. - carcinoma della mammella - synthetika

Schweiz - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - palbociclibum - capsule rigide - palbociclibum 125 mg, cellulosum microcristallinum, lactosum monohydricum 92.958 mg, carboxymethylamylum natricum a, silica colloidalis anhydrica, magnesii stearas, kapselhülle: gelatina, e 172 (rubrum), e 172 (flavum), e 171, drucktinte: lacca, e 171, ammoniae solutio 28 per centum, propylenglycolum, simeticonum, pro capsula, natrium 2.13 mg. - carcinoma della mammella - synthetika

Schweiz - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - bosutinibum - compresse rivestite con film - bosutinibum 100 mg ut bosutinibum monohydricum, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.261 mg, poloxamerum 188, povidonum k 25, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, e 171, e 172 (flavum), pro compresso obducto. - onkologikum - synthetika

Schweiz - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - bosutinibum - compresse rivestite con film - bosutinibum 500 mg ut bosutinibum monohydricum, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 1.044 mg, poloxamerum 188, povidonum k 25, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, e 171, e 172 (rubrum), pro compresso obducto. - onkologikum - synthetika

Schweiz - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer pfe switzerland gmbh - tolterodinum - retard-kapseln - tolterodini-l-tartras 2 mg corresp. tolterodinum 1.37 mg, color.: e 132, excipiens pro capsula. - behandlung der hyperaktiven blase - synthetika human

Schweiz - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer pfe switzerland gmbh - tolterodinum - retard-kapseln - tolterodini-l-tartras 4 mg corresp. tolterodinum 2.74 mg, color.: e 132, excipiens pro capsula. - behandlung der hyperaktiven blase - synthetika human

Schweiz - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - bosutinibum - compresse rivestite con film - bosutinibum 400 mg ut bosutinibum monohydricum, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 1.31 mg, poloxamerum 188, povidonum k 25, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, e 171, e 172 (rubrum), e 172 (flavum), pro compresso obducto. - onkologikum - synthetika

Schweiz - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - dacomitinibum - compresse rivestite con film - dacomitinibum 15 mg per dacomitinibum monohydricum, cellulosum microcristallinum, lactosum monohydricum 40.462 mg, carboxymethylamylum natricum un corrisp. sodio max. 0.126 mg, magnesio stearas, Überzug: poli(alcole vinylicus), talco, e 171, macrogolum 3350, e 132, per compresso haze. - non tumori polmonari a piccole carcinoma polmonare (nsclc) - synthetika

Schweiz - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - dacomitinibum - compresse rivestite con film - dacomitinibum 30 mg a dacomitinibum monohydricum, cellulosum microcristallinum, lactosum monohydricum 80.924 mg, carboxymethylamylum natricum un corrisp. sodio max. 0.252 mg, magnesio stearas, Überzug: poli(alcole vinylicus), talco, e 171, macrogolum 3350, e 132, per compresso haze. - non tumori polmonari a piccole carcinoma polmonare (nsclc) - synthetika